Physician
General Surgery
Dr. Igal Kam, MD
|
|
Give Review
Igal Kam is an expert in the field of General Surgery. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Igal is also published. He has 49 publications published. The lastest publication: "Sirolimus reduces the risk of significant hepatic fibrosis after liver transplantation for hepatitis C virus: a single-center experience.' Igal is registered with Medicare.
Publications
- Sirolimus reduces the risk of significant hepatic fibrosis after liver transplantation for hepatitis C virus: a single-center experience.
- Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.
- Biological Implications of Extracellular Adenosine in Hepatic Ischemia and Reperfusion Injury.
- Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver.
- Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
- Subcutaneous Administration of Glargine to Diabetic Patients Receiving Insulin Infusion Prevents Rebound Hyperglycemia.
- Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
- Adult-to-adult transplantation of the right hepatic lobe from a living donor.
- Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late.
- Reduced use of intensive care after liver transplantation: influence of early extubation.
- Reduced use of intensive care after liver transplantation: patient attributes that determine early transfer to surgical wards.
- Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation.
- Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications.
- Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
- Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
- Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
- Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.
- Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava.
- Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation.
- Pediatric liver transplantation.
- Atrial septal perforation from TIPS stent migration.
- Hepatic artery pseudoaneurysm - duodenal fistula after living donor liver transplant.
- A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.
- Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.
- Herpes simplex in a liver transplant recipient.
- Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma.
- Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
- Hepatocellular carcinoma in a noncirrhotic patient with hereditary hemochromatosis.
- A multicenter evaluation of safety of early extubation in liver transplant recipients.
- Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.
- Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
- Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: a single-center study of 109 cases.
- Adjustable gastric banding in a morbidly obese patient during liver transplantation.
- Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal.
- Bariatric surgery in liver transplant patients: weighing the evidence.
- Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation.
- Transplant tourism and unregulated black-market trafficking of organs.
- Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation.
- The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation.
- Donor complications following laparoscopic compared to hand-assisted living donor nephrectomy: an analysis of the literature.
- May-Thurner syndrome complicating left-sided renal transplant.
- Direct Anastomosis of the Donor Hepatic Artery to the Supraceliac Aorta without Extension Graft during Adult Liver Transplant in the Era of Extended Criteria Donors: R...
- Combined piggyback technique and cavoportal hemitransposition for liver transplant.
- Choledochoduodenostomy in pediatric liver transplantation.
- Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.
- Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience.
- A Decade of Experience Using mTor Inhibitors in Liver Transplantation.
- Multiple rib fractures secondary to severe tardive dystonia and respiratory dyskinesia.
Schools
Institute Of Technology
University Of Pittsburgh Medical Center
Doctors Specialties
- Transplant Surgery
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Whole Health Colorado Front Range
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1558455881 | |
| NPPES Provider LastName | KAM | |
| NPPES Provider FirstName | IGAL | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | General Surgery | |
| Total Claim Count | 46.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558455881 |
| Last Name Of The Provider | KAM |
| First Name Of The Provider | IGAL |
| View All |
Similar Doctors
|
Dr. Jonathan A. Schoen, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael E. Wachs, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael A. Zimmerman, MD |
|
Dr. Nathan W. Pearlman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Esam M. Aboutaleb, MD |
|
|
Dr. Maria B. Albuja-Cruz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yihan Lin, MD |